Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis

Microscopy Research and Technique

Volumn 76, Issue 12, 2013, Pages 1250-1256

  Fonseca Alves, Carlos E ^a   Rodrigues, Marcela M P ^b   de Moura, Veridiana M B D ^c   Rogatto, Silvia R ^b,d   Laufer Amorim, Renee ^a  

^a School of Animal Science and Food Engineering   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Canine; Immunohistochemistry; Prostatic carcinoma; Protein expression

Indexed keywords

GLYCOPROTEINS; PATHOLOGY; TISSUE; UROLOGY;

BASAL CELLS; CANINE; CANIS LUPUS; CARCINOGENESES; E-CADHERIN EXPRESSION; E-CADHERINS; IMMUNOHISTOCHEMISTRY; PROSTATE CARCINOGENESIS; PROSTATIC CARCINOMA; PROTEIN EXPRESSIONS;

CELL PROLIFERATION;

ANIMALIA; CANIS FAMILIARIS;

CADHERIN; CKAP4 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MEMBRANE PROTEIN; MYC PROTEIN; MYC PROTEIN, HUMAN; NKX3 1 PROTEIN, HUMAN; NKX3-1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; CANINE; CELL PROLIFERATION; CELL TRANSFORMATION; DISEASE MODEL; DOG; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; PROSTATE; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATE TUMOR; PROTEIN EXPRESSION; TISSUE MICROARRAY;

CANINE; IMMUNOHISTOCHEMISTRY; PROSTATIC CARCINOMA; PROTEIN EXPRESSION;

ANIMALS; CADHERINS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DOGS; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84887826617     PISSN: 1059910X     EISSN: 10970029     Source Type: Journal    
DOI: 10.1002/jemt.22292     Document Type: Article

References (43)

1. Arcolino FO, Ribeiro DL, Gobbo MG, Taboga SR, Góes RM. 2010. Proliferation and apoptotic rates and increased frequency of p63-positive cells in the prostate acinar epithelium of alloxan induced diabetic rats. Int J Exp Pathol 91:144-154.
2. Anderson PD, Mckissic SA, Logan M, Roh M, Franco OE, Wang F, Doubinskaia I, Meer RVD, Hayward SW, Eischen CM, Eltoum IE, Adbulkadir SA. 2012. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. J Clin Invest 122:1907-1919.
3. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, Shen CA, Shen MM. 1999. Roles for Nkx3.1 in prostate development and cancer. Genes Dev 13:966-977.
4. Dolores JL, Zhang L. 2005. Challenges in prostate cancer research: Animal models for nutritional studies of chemoprevention and disease progression. J Nutr 135:3009S-3015S.
5. Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang JF, Matusik R, Thomas GV, Sawyers CL. 2003. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4:223-238.
6. Fonseca-Alves CE, Faleiro MB, Laufer-Amorim R, de Moura VMBD. 2010. Prostatic histological evaluation in adult not castrated dogs. Arq Bras Med Vet Zootec 62:10-29.
7. Fonseca-Alves CE, Corrêa AG, Santos-Júnior HL, Elias F, Costa SS, de Moura VMBD. 2012. Prostatic abscess in dogs: Report of 15 cases. Semina Ciênc Agrar 33:1157-1164.
8. Foster RA, Ladds PW. Male genital system. In: Jubb KVF, Kennedy PC, Palmer N, editors. Pathology of domestic animals. St. Louis, MI: Elsevier. 2007. p 590.
9. Gallucci M, Merola R, Leonardo C, de Carli P, Farsetti A, Sentinelli S, Sperduti I, Mottolese M, Carlini P, Vico E, Simone G, Cianciulli A. 2009. Genetic profile identification in clinically localized prostate carcinoma. Urol Oncol 27:502-508.
10. Gupta GP, Massague J. 2006. Cancer metastasis: Building a framework. Cell 127:679-695.
11. Gurel B, Iwata T, Koh CM, Jenkins RB, Lan F, van Dang C, Hicks LJ, Morgan J, Cornish TC, Sutcliffe S, Isaacs WB, Luo J, de Marzo AM. 2008. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod Pathol 21:1156-1167.
12. Grisanzio C, Signoretti S. 2008. p63 in prostate biology and pathology. J Cell Biochem 103:1354-1368.
13. Inouea M, Shiramizub K. 1999. Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumours. J Comp Pathol 120:169-175.
14. Iwata T, Schultz D, Hicks J, Hubbard GK, Mutton LN, Lotan TL, Bethel C, Lotz MT, Yegnasubramanian S, Nelson WG, Dang CV, Xu M, Anele U, Koh CM, Bieberich CJ, de Marzo AM. 2010. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells. PLoS One 5:1-16.
15. Kindich R, Florl AR, Kamradt J, Lehmann J, Muller M, Wullich B, Schulz WA. 2006. Relationship of NKX3.1 and MYC gene copy number ratio and DNA hypomethylation to prostate carcinoma stage. Eur Urol 49:169-175.
16. Koh CM, Bieberich CJ, Dang CV, Nelson WG, Yegnasubramanian S, de Marzo AM. 2010. MYC and prostate cancer. Genes Cancer 1:617-628.
17. Leav I, Schelling KH, Adams JY, Merk FB, Alroy J. 2001. Role of canine basal cells in prostatic post-natal development, induction of hyperplasia, sex hormone-stimulated growth, and the ductal origin of carcinoma. Prostate 1:149-163.
18. Leroy BE, Nadella MV, Toribio RE, Leav I, Rosol TJ. 2004. Canine prostate carcinomas express markers of urothelial and prostatic differentiation. Vet Pathol 41:131-140.
19. Leroy BE, Northrup N. 2009. Prostate cancer in dogs: Comparative and clinical aspects. Vet J 180:149-162.
20. Locke JA, Zafarana G, Ishkanian AS, Milosevic M, Thoms J, Have CL, Malloff CA, Lam WL, Squire JA, Pintilie M, Sykes J, Ramnarine VR, Meng A, Ahmed O, Jurisica I, van der Kwast T, Bristow RG. 2012. NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapy. Clin Cancer Res 18:308-316.
21. Mani SA, Guo W, Liao MJ, Eaton E, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cancer Cell 133:704-715.
22. Matsuzaki P, Cogliat IB, Sanche SDS, Chaible LM, Kimura KC, Silva TC, Real-Lima MA, Hernandez-Blazquez FJ, Laufer-Amorim R, Dagli MLZ. 2010. Immunohistochemical characterization of canine prostatic intraepithelial neoplasia. J Comp Pathol 142:84-88.
23. Nakagawa M, Yamanaka S. 2012. Function of Myc for generation of induced pluripotent stem cells. Stem Cells Cancer Stem Cells 6:79-85.
24. Nelson WG, de Marzo AM, Isaacs WB. 2003. Prostate cancer. N Engl J Med 349:366-381.
25. Nowak M, Madejand JA, Dziêgiel P. 2007. Expression of E-cadherin, β-catenin and Ki-67 antigen and their reciprocal relationships in mammary adenocarcinomas in bitches. Folia Histochem Cytobiol 45:233-238.
26. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. 2008. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68:3645-3654.
27. Parsons JK, Gage WR, Nelson WG, de Marzo AM. 2001. p63 protein expression is rare in prostate adenocarcinoma: Implications for cancer diagnosis and carcinogenesis. Urology 58:619-624.
28. Pelengaris S, Khan M, Evan G. 2002. c-MYC: More than just a matter of life and death. Nat Rev Cancer 2:764-776.
29. Prowatke I, Devens F, Benner A, Gröne EF, Mertens D, Gröne HJ, Lichter P, Joos S. 2007. Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. Br J Cancer 96:82-88.
30. Rimm DL, Camp RL, Olsen DA, Provos E. 2001. Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol 70:255-264.
31. Rodrigues MMPR, Rema A, Gartner MF, Laufer-Amorim R. 2013. Role of adhesion molecules and proliferation hyperplasic, pre neoplastic and neoplastic lesions in canine prostate. Pak J Biol Sci 16:1324-1329.
32. Rossignol P, Bouton MC, Jandrot-Perrus M, Bryckaert M, Jacob MP, Bezeaud A, Guillin MC, Michel JB, Meilhac O. 2004. A paradoxical pro-apoptotic effect of thrombin on smooth muscle cells. Exp Cell Res 299:279-278.
33. Royuela M, Miguel MP, Ruiz A, Fraile B, Arenas MI, Romo E, Paniagua R. 2000. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: Parallelism with c-myc and p53 expression. Eur Cytokine Netw 1:119-127.
34. Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML. 2001. E-cadherin expression in prostate cancer: A broad survey using high-density tissue microarray technology. Hum Pathol 32:690-697.
35. Saha B, Arase A, Imam SS, Tsao-Wei D, Naritoku WY, Groshen S, Jones LW, Imam SA. 2008. Overexpression of E-cadherin and β-catenin proteins in metastatic prostate cancer cells in bone. Prostate 68:78-84.
36. Sheikh H, Ali S, Sinha R, Lipton A. 2013. Impact of genetic targets on prostate cancer therapy. Adv Exp Med Biol 779:359-383.
37. Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics. CA Cancer J Clin 62:10-29.
38. Song H, Zhang B, Watson MA, Humphrey PA, Lim H, Milbrandt J. 2009. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene 28:3307-3319.
39. Toledo DC, Faleiro MBR, Rodrigues MMP, Di Santis GW, Laufer-Amorim R, de Moura VMBD. 2010. Histomorphological characterization of proliferative inflammatory atrophy in canine prostate. Cienc Rural 40:1372-1377.
40. Voeller HJ, Augustus M, Madike V, Bova GS, Carter KC, Gelmann EP. 1997. Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Res 57:4455-4459.
41. Zafarana G, Ishkanian AS, Locke JA, Mmath JS, Thoms J, Lam WL, Squire JA, Yoshimoto M, Ramnarine VR, Meng A, Ahmed O, Jurisca I, Milosevic M, Pintile M, Kwast TV, Bristow RG. Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy. Cancer 118:4053-4062.
42. Williams K, Fernandez S, Stien X, Ishii K, Love HD, Lau YF, Roberts RL, Hayward SW. 2005. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Prostate 63:369-384.
43. Winter SF, Cooper AB, Greenberg NM. 2003. Models of metastatic prostate cancer: A transgenic perspective. Prost Cancer Prost Dis 6:204-211.